StockIQStockIQ.tech
Account
Register Login

Avantor, Inc. (AVTR) Stock Analysis

--

Free AI-powered analysis and research for Avantor, Inc. stock

Sector: Healthcare

AVTR snapshot

Data as of 12 Oct 2026 close. Updated daily.

Last close
15.49 USD (-1.15%)
52-week range
7.26 – 16.38
Position in range
90%
1-year change
+12.4%
Market cap (USD)
$10.5B
RSI (14-day)
57
vs 200-day average
+42.6%
MACD
Below signal line
StockIQ score: 42/100 · Mixed signals

Avantor, Inc. scores 42/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 90% of its 52-week range, up 12.4% over the past year. Latest reported figures show a profit margin of -8.8%, return on equity of -9.7% and revenue growth of +0.5%.

What is driving the score
  • RSI Neutral: +5
  • Strong Uptrend: +9
  • MACD Bearish: -8
  • Unprofitable (-8.8%): -15
  • Negative ROE (-9.7%): -10
  • Strong Long-term Uptrend: +8
  • Up Over 1 Year (+12.4%): +3

Automated, general information only – not financial advice. Scores can be wrong. How the score works

Full AVTR report

Avantor, Inc. (AVTR) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze AVTR Now β†’

πŸ“° Latest Update

Avantor Stock Has Strong Technical Momentum, But Make Sure Your Stop Losses Are Tight

Avantor (AVTR) has demonstrated strong technical momentum, indicating positive market sentiment and potential for further gains. However, analysts advise investors to implement tight stop losses to mitigate risks associated with market volatility. This guidance is crucial for investors looking to capitalize on the stock's upward trend while protecting their investments from sudden downturns.

Read full article β†’

History

People also watch

ISRG
Intuitive Surgical Inc.
--
MRK
Merck & Co. Inc.
--
ABT
Abbott Laboratories
--
CRDF
Cardiff Oncology, Inc.
--
NGNE
Neurogene Inc.
--